Privium Fund Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$127K	Buy	111,090 +2,064	+2%	+$2.35K	0.03%	54
2025 Q1	$86.1K	Buy	109,026 +22,026	+25%	+$17.4K	0.02%	55
2024 Q4	$144K	Buy	87,000 +37,000	+74%	+$61.1K	0.03%	61
2024 Q3	$175K	Buy	+50,000	New	+$175K	0.04%	76